• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定临床状态和急性加重期慢性阻塞性肺疾病患者气道微生物群:一项支气管镜检查研究

Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

作者信息

Pela R, Marchesani F, Agostinelli C, Staccioli D, Cecarini L, Bassotti C, Sanguinetti C M

机构信息

Dept of Pulmonology, City Hospital, Osimo, Ancona, Italy.

出版信息

Monaldi Arch Chest Dis. 1998 Jun;53(3):262-7.

PMID:9785808
Abstract

Patients affected with chronic obstructive pulmonary disease (COPD) undergo frequent exacerbations of their illness characterized by increased cough and expectoration. The precise aetiology of these episodes often remains unknown. In the absence of clinical or radiographic signs of pneumonia, bacterial or viral cultures of sputum usually provide little useful information. Thus, we performed fibreoptic bronchoscopy using a protected specimen brush (PSB) to obtain uncontaminated secretions for culture from 56 patients with COPD, 16 with stable clinical conditions and 40 affected with exacerbations of the disease. The aim of our study was to evaluate bronchial microbial flora by quantitative aerobic and anaerobic culture of each specimen. Twenty five subjects (45%), 4 (16%) in stable state and 21 (84%) with COPD exacerbations, had specimens which gave rise to significant bacterial growth (> 10(3) colony forming units.mL-1). The predominant bacteria were Streptococcus pneumoniae (in 10 cases) and alpha-haemolytic streptococci (in 6 cases); other bacteria found were coagulase-negative staphylococci and Branhamella catarralis in (2 cases each), and Proteus mirabilis, Haemophilus influenzae, Pseudomonas aeruginosa, Aerococcus viridans and Chromobacterium violaceum (each in a single case only). Although significant bacterial growth was more frequently found in patients with chronic obstructive pulmonary disease exacerbations and in those with a higher degree of bronchial inflammation, the differences between the two groups of patients were not statistically significant. Nevertheless, the results obtained in our study confirm the validity of and the need for reliable sampling methods (like the protected specimen brush) to demonstrate significant bacterial colonization of the airways in chronic obstructive pulmonary disease patients.

摘要

慢性阻塞性肺疾病(COPD)患者常经历病情频繁加重,其特征为咳嗽和咳痰增多。这些发作的确切病因通常仍不清楚。在没有肺炎的临床或影像学迹象的情况下,痰的细菌或病毒培养通常提供的有用信息很少。因此,我们使用保护性标本刷(PSB)对56例COPD患者进行了纤维支气管镜检查,其中16例临床状况稳定,40例病情加重。我们研究的目的是通过对每个标本进行需氧和厌氧定量培养来评估支气管微生物菌群。25名受试者(45%),稳定状态下有4名(16%),COPD加重期有21名(84%),其标本有显著细菌生长(>10³菌落形成单位/mL)。主要细菌是肺炎链球菌(10例)和α溶血性链球菌(6例);还发现其他细菌有凝固酶阴性葡萄球菌和卡他布兰汉菌(各2例),以及奇异变形杆菌、流感嗜血杆菌、铜绿假单胞菌、绿色气球菌和紫色色杆菌(各仅1例)。虽然在慢性阻塞性肺疾病加重期患者和支气管炎症程度较高的患者中更常发现显著细菌生长,但两组患者之间的差异无统计学意义。然而,我们研究获得的结果证实了可靠采样方法(如保护性标本刷)在证明慢性阻塞性肺疾病患者气道中显著细菌定植方面的有效性和必要性。

相似文献

1
Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.稳定临床状态和急性加重期慢性阻塞性肺疾病患者气道微生物群:一项支气管镜检查研究
Monaldi Arch Chest Dis. 1998 Jun;53(3):262-7.
2
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1316-20. doi: 10.1164/ajrccm.152.4.7551388.
3
Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.健康受试者和慢性肺病患者远端气道的细菌定植:一项支气管镜研究。
Eur Respir J. 1997 May;10(5):1137-44. doi: 10.1183/09031936.97.10051137.
4
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.需要机械通气的慢性阻塞性肺疾病(COPD)严重加重期的支气管微生物模式。
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1498-505. doi: 10.1164/ajrccm.157.5.9711044.
5
The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?慢性支气管炎患者的支气管内微生物群:N-乙酰半胱氨酸治疗的靶点?
Eur Respir J. 1994 Jan;7(1):94-101. doi: 10.1183/09031936.94.07010094.
6
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的微生物学决定因素
Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891.
7
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中细菌定植的易感因素。
Eur Respir J. 1999 Feb;13(2):343-8. doi: 10.1034/j.1399-3003.1999.13b21.x.
8
[Chronic obstructive pulmonary disease and bronchial colonization/infection].[慢性阻塞性肺疾病与支气管定植/感染]
Presse Med. 2001 Oct 27;30(31 Pt 2):11-5.
9
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.2000年慢性阻塞性肺疾病中的细菌感染:最新综述
Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001.
10
Absence of bacterial colonization of the airways after therapeutic rigid bronchoscopy without stenting.
Eur Respir J. 2000 Dec;16(6):1147-51. doi: 10.1034/j.1399-3003.2000.16f22.x.

引用本文的文献

1
The Role of Early Warning Scoring Systems NEWS and MEWS in the Acute Exacerbation of COPD.早期预警评分系统NEWS和MEWS在慢性阻塞性肺疾病急性加重中的作用
Clin Med Insights Circ Respir Pulm Med. 2023 Jan 24;17:11795484231152305. doi: 10.1177/11795484231152305. eCollection 2023.
2
Chronic Obstructive Pulmonary Disease: Inpatient Management.慢性阻塞性肺疾病:住院治疗管理
Hosp Med Clin. 2013 Apr;2(2):e169-e191. doi: 10.1016/j.ehmc.2012.12.001. Epub 2013 Mar 18.
3
Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review.
解决 COPD 中的病毒诱导的继发性细菌感染:简要综述。
Front Immunol. 2018 Oct 16;9:2345. doi: 10.3389/fimmu.2018.02345. eCollection 2018.
4
Dysregulated Functions of Lung Macrophage Populations in COPD.COPD 中肺巨噬细胞群体功能失调。
J Immunol Res. 2018 Feb 18;2018:2349045. doi: 10.1155/2018/2349045. eCollection 2018.
5
Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.扎氟沙星与莫西沙星治疗慢性阻塞性肺疾病急性加重患者的疗效比较:一项多中心、双盲、双模拟、随机、对照、III期、非劣效性试验。
Int J Chron Obstruct Pulmon Dis. 2015 Oct 22;10:2265-75. doi: 10.2147/COPD.S90948. eCollection 2015.
6
Positioning new pharmacotherapies for COPD.为慢性阻塞性肺疾病定位新的药物治疗方法。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 24;10:1427-42. doi: 10.2147/COPD.S83758. eCollection 2015.
7
Targeting pro-resolution pathways to combat chronic inflammation in COPD.靶向促消退途径以对抗慢性阻塞性肺疾病中的慢性炎症。
J Thorac Dis. 2014 Nov;6(11):1548-56. doi: 10.3978/j.issn.2072-1439.2014.08.08.
8
Role of alveolar macrophages in chronic obstructive pulmonary disease.肺泡巨噬细胞在慢性阻塞性肺疾病中的作用。
Front Immunol. 2014 Sep 10;5:435. doi: 10.3389/fimmu.2014.00435. eCollection 2014.
9
Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa.过氧化氢酶(KatA)在铜绿假单胞菌抵御厌氧一氧化氮的过程中发挥作用。
PLoS One. 2014 Mar 24;9(3):e91813. doi: 10.1371/journal.pone.0091813. eCollection 2014.
10
The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD.慢性阻塞性肺疾病急性加重期患者痰液中最常检测到的细菌
Mater Sociomed. 2013 Dec;25(4):226-9. doi: 10.5455/msm.2013.25.226-229. Epub 2013 Nov 24.